Literature DB >> 21979372

A fibroblast/macrophage co-culture model to evaluate the biocompatibility of an electrospun Dextran/PLGA scaffold and its potential to induce inflammatory responses.

Hui Pan1, Hongliang Jiang, Sarah Kantharia, Weiliam Chen.   

Abstract

Fibroblasts and macrophages are the two major types of cells responding to implanted biomaterials. They play crucial roles in inflammatory responses, host-material interactions and tissue remodeling. However, the synergistic interactions of these two cell types with biomaterials are not fully understood. In this investigation, an in vitro fibroblast/macrophage co-culture system was utilized to examine the biocompatibility and the potential to induce inflammatory responses of an electrospun Dextran/PLGA scaffold. The scaffold did not affect the morphologies, attachments, proliferations and viabilities of both the fibroblasts and macrophages, cultured separately or together. Moreover, it only activated a small subset of the macrophages implicating a low potential to induce either severe acute or chronic inflammatory response. Additionally, fibroblasts played a role in prolonging macrophage activation in the presence of the scaffolds. Using antibody arrays, IL-10, SDF-1, MIP-1 gamma and RANTES were found to be up-regulated when the cells were incubated with the scaffolds. The results of subdermal implantation of the Dextran/PLGA scaffolds confirmed its biocompatibility and low inflammatory potential.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979372     DOI: 10.1088/1748-6041/6/6/065002

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  7 in total

1.  Effects of mesenchymal stem cell and fibroblast coating on immunogenic potential of prosthetic meshes in vitro.

Authors:  Yue Gao; David M Krpata; Cory N Criss; Lijia Liu; Natasza Posielski; Michael J Rosen; Yuri W Novitsky
Journal:  Surg Endosc       Date:  2014-06-28       Impact factor: 4.584

2.  Human fibroblast-macrophage tissue spheroids demonstrate ratio-dependent fibrotic activity for in vitro fibrogenesis model development.

Authors:  Yu Tan; Allister Suarez; Matthew Garza; Aadil A Khan; Jennifer Elisseeff; Devin Coon
Journal:  Biomater Sci       Date:  2020-03-31       Impact factor: 6.843

3.  The influence of surface modified poly(l-lactic acid) films on the differentiation of human monocytes into macrophages.

Authors:  Clara R Correia; Joana Gaifem; Mariana B Oliveira; Ricardo Silvestre; João F Mano
Journal:  Biomater Sci       Date:  2017-02-28       Impact factor: 6.843

4.  Towards an in vitro model mimicking the foreign body response: tailoring the surface properties of biomaterials to modulate extracellular matrix.

Authors:  Febriyani F R Damanik; Tonia C Rothuizen; Clemens van Blitterswijk; Joris I Rotmans; Lorenzo Moroni
Journal:  Sci Rep       Date:  2014-09-19       Impact factor: 4.379

5.  Biocompatibility Assessment of a New Biodegradable Vascular Graft via In Vitro Co-culture Approaches and In Vivo Model.

Authors:  Marjan Enayati; Magdalena Eilenberg; Christian Grasl; Peter Riedl; Christoph Kaun; Barbara Messner; Ingrid Walter; Robert Liska; Heinrich Schima; Johann Wojta; Bruno K Podesser; Helga Bergmeister
Journal:  Ann Biomed Eng       Date:  2016-04-07       Impact factor: 3.934

6.  Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response.

Authors:  Nathaniel M Vacanti; Hao Cheng; Paulina S Hill; João D T Guerreiro; Tram T Dang; Minglin Ma; Shanée Watson; Nathaniel S Hwang; Robert Langer; Daniel G Anderson
Journal:  Biomacromolecules       Date:  2012-09-11       Impact factor: 6.988

7.  Foreign body reaction associated with PET and PET/chitosan electrospun nanofibrous abdominal meshes.

Authors:  Beatriz Veleirinho; Daniela S Coelho; Paulo F Dias; Marcelo Maraschin; Rúbia Pinto; Eduardo Cargnin-Ferreira; Ana Peixoto; José A Souza; Rosa M Ribeiro-do-Valle; José A Lopes-da-Silva
Journal:  PLoS One       Date:  2014-04-16       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.